Elias Eg

667 total citations
31 papers, 515 citations indexed

About

Elias Eg is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elias Eg has authored 31 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elias Eg's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Elias Eg is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Treatment and Pharmacology (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Elias Eg collaborates with scholars based in United States. Elias Eg's co-authors include Karakousis Cp, Aust Jb, Grage Tb, Antonio Brugarolas, Holyoke Ed, Nancy O. Whitley, Mason Gr, A Mittelman, Douglass Ho and Mukund S. Didolkar and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Elias Eg

31 papers receiving 453 citations

Peers

Elias Eg
Comparison fields: 5 of 65
  • Surgery 245
  • Oncology 229
  • Hepatology 164
  • Pulmonary and Respiratory Medicine 125
  • Epidemiology 88
Replace Sheldon Kaufman with:
Sheldon Kaufman United States
Tatsuro Kamakura Japan
Jung Chul Kim South Korea
Süheyla Serdengeçti Türkiye
Thorbjörn Berge Sweden
Pankaj Prasoon China
Hirofumi Tazawa Japan
Hiroyuki Sugo Japan
Ju Yeon Pyo South Korea
Shigeru Kuramochi Japan
Sheldon Kaufman United States View profile →
Citations per field, relative to Elias Eg
Elias Eg · 1×
Citations per year, relative to Elias Eg
Elias Eg · 1×

Countries citing papers authored by Elias Eg

Since Specialization
Citations

This map shows the geographic impact of Elias Eg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Eg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Eg more than expected).

Fields of papers citing papers by Elias Eg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Eg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Eg. The network helps show where Elias Eg may publish in the future.

Co-authorship network of co-authors of Elias Eg

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Eg. A scholar is included among the top collaborators of Elias Eg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Eg. Elias Eg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Complications of operative and endoscopic gastrostomies.
3
2
Adjuvant therapy for carcinoma of the rectum.
1
3
Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure.
59
4
Do polyps become cancer?
1
5
Unresectable hepatic metastases from carcinoma of the colon and rectum.
9
6
Carcinoma of the breast: Part 3, Therapeutic approaches.
1
7
Maintenance of function and esthetics after partial mandibulectomy without bone grafting.
11
8
Carcinoma of the colon and rectum: Part 2, staging and prognosis.
1
9
Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil vs. intravenous 5-fluorouracil in patients with hepatic metastases from colo-rectal cancer: a Central Oncology Group Study (COG 7032).
3
10
Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study.
127
11
Delorme's repair for rectal prolapse.
5
12
A clinicopathologic study of prognostic factors in cutaneous malignant melanoma.
57
13
Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy.
3
14
Evaluation of forequarter amputation in malignant diseases.
18
15
Primary neoplasms of the duodenum.
26
16
Evaluation of splenectomy in chronic myelogenous leukemia.
3
17
Endoscopy in patients with malignant conditions of the gastrointestinal tract.
2
18
Spontaneous (pathologic) rupture of spleen in malignancies.
31
19
Blood coagulation and fibrinolysis in patients with carcinoma of the lung.
15
20
Correlation of hyperfibrinogenemia with major thromboembolism in patients with cancer.
16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026